Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda takes another step into India with Advinus R&D alliance

This article was originally published in Scrip

Executive Summary

There has long been speculation that Takeda may be in line for a commercial acquisition in India, but for the time being at least Asia's largest pharma firm has opted for the collaborative R&D approach.

You may also be interested in...



Takeda-Advinus R&D Alliance ‘Closed’

Takeda’s alliance with Advinus Therapeutics, a much-touted deal that had put the spotlight on the Indian R&D services firm, has ended. Advinus is currently in the process of divesting of its contract research business to Eurofins Scientific.

Will Eurofins Deal See Advinus Turn The Corner?

Eurofins Scientific has snapped up the contract research business of Advinus Therapeutics, continuing its ongoing acquisition momentum. The deal also ends long-running speculation around a potential sale of Advinus, amid its rocky recent run.

QUOTED. 28 October 2020. Serge Bernasconi.

A new report focused on the European market says that winning trust is the key to taking AI adoption to the next stage. That approach was praised by MedTech Europe CEO Serge Bernasconi.

Topics

Related Companies

UsernamePublicRestriction

Register

ID1132046

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel